MT-3014

Also Known As:

1-((2-(7-fluoro-3-methylquinoxalin-2-yl)-5-((3R)-3-fluoropyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-7-yl)amino)-2-methylpropan-2-ol

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Cognitive Dysfunction 01/01/2020 - "These results suggest that MT-3014 may be a novel antipsychotic drug, which is expected to have additional effects on cognitive impairment, without the prominent side effects associated with current atypical antipsychotics."
2.	Catalepsy 01/01/2020 - "Interestingly, MT-3014 did not elicit catalepsy and plasma prolactin increases at high doses. "

1.	Antipsychotic Agents (Antipsychotics)
2.	Prolactin